News tagged with cancer vaccine

New test to predict the effectiveness of cancer vaccines

Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that are directed against so-called neoantigens: These are proteins that have undergone ...

Feb 19, 2015
popularity 5 / 5 (3) | comments 0

HPV vaccination not linked to riskier sex

Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, ...

Feb 09, 2015
popularity 4 / 5 (4) | comments 2

Novel concept for HIV and cancer vaccines

A team of specialists from the Institute of Biomedical Research at the National Autonomous University of Mexico (UNAM) is developing a vaccine against HIV / AIDS and cancer. An experimental trial has demonstrated ...

Feb 04, 2015
popularity 3.8 / 5 (4) | comments 1

New HPV vaccine strengthens cancer protection

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.

Dec 10, 2014
popularity 4.8 / 5 (6) | comments 0

Vaccines may make war on cancer personal

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...

Nov 26, 2014
popularity 4.5 / 5 (6) | comments 0

Cancer vaccine

The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, treats existing cancer or prevents the development of cancer in certain high risk individuals.

Some cancers, such as cervical cancer and some liver cancers, are caused by viruses, and traditional vaccines against those viruses, such as HPV vaccine and Hepatitis B vaccine, will prevent those cancers.

Scientists have also been trying to develop vaccines against existing cancers. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system; cancer forms when the immune system fails to destroy them. One approach to cancer vaccination is to separate proteins from cancer cells and immunize cancer patients against those proteins, in the hope of stimulating an immune reaction that would kill the cancer cells. Therapeutic cancer vaccines are being developed for the treatment of breast, lung, colon, skin, kidney, prostate, and other cancers..

On April 14 2009 Dendreon Corporation announced that their Phase III clinical trial of Provenge, a cancer vaccine designed to treat prostate cancer, had succeeded in demonstrating an increase in survival. This is the first robust, statistically significant Phase III result for a cancer vaccine, although the data have yet to be scrutinized by the U.S. Food and Drug Administration or by European Union regulatory agencies. Dendreon is forecasting marketing approval by the FDA by 2010

If Provenge is approved by the FDA, Dendreon will have opened a new era in cancer care.[citation needed]

This text uses material from Wikipedia licensed under CC BY-SA